Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Gestational age of at least 16 weeks.~* P. falciparum parasitaemia of any density with or without symptoms.~* Informed consent.~* No known adverse reaction to any of the study drugs.~* Residence in the study area.~Exclusion Criteria:~* Past obstetric and medical history that might adversely affect the interpretation of outcomes such as repeated stillbirths and eclampsia.~* History of severe adverse drug reactions to co-trimoxazole in the past.~* Haemoglobin concentration below 5.0 g/dl.~* Severe malaria.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).